A Phase 2 Study with Epirubicin as Second-Line Treatment of Patients with Advanced Epithelial Ovarian Cancer

Author: Havsteen H.   Bertelsen K.   Gadeberg C.C.   Jacobsen A.   Kamby C.   Sandberg E.   Sengelov L.  

Publisher: Academic Press

ISSN: 0090-8258

Source: Gynecologic Oncology, Vol.63, Iss.2, 1996-11, pp. : 210-215

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content